YTHDC1 and osteoporosis: Our research revealed that WTAP could promote osteogenic differentiation and inhibit adipogenic differentiation of BMSCs through the YTHDC1/ miR-181a and miR-181c /SFRP1 axes, which could be of significance in developing therapeutic targets for osteoporosis.